SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-23-012492
Filing Date
2023-10-20
Accepted
2023-10-20 17:07:54
Documents
12
Period of Report
2023-10-17
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_101723.htm   iXBRL 8-K 24750
  Complete submission text file 0001387131-23-012492.txt   195926

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE tnxp-20231017.xsd EX-101.SCH 3024
3 XBRL LABEL FILE tnxp-20231017_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE tnxp-20231017_pre.xml EX-101.PRE 22365
6 EXTRACTED XBRL INSTANCE DOCUMENT tnxp-8k_101723_htm.xml XML 3191
Mailing Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928
Business Address 26 MAIN STREET, SUITE 101 CHATHAM NJ 07928 212-980-9155
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 231337706
SIC: 2834 Pharmaceutical Preparations